Charles River Laboratories’ Post

Your individual drug development needs are important, and your drug’s journey requires a customized approach. Learn how our investment in your success translates to a collaborative experience. https://okt.to/zEebVi

Getting your study data as quickly as possible is essential to maintain momentum and move your IND program forward. Our #Kansas facility provides data as real-time as possible with Charles River’s Apollo™, so that you can make decisions swiftly and with confidence. https://okt.to/f59DGZ

Are you looking for guidance with #Endocrine Disruptor testing to meet ECHA requirements? We offer regulatory support and customized comprehensive testing solutions for your in vitro and in vivo needs. ASK OUR EXPERTS: https://okt.to/xhMzqA

Human iPSC-derived neurons and glial cells are a robust and reproducible alternative to primary cells for modelling neuronal connections and #neuroinflammatory processes. At #Neuroscience 2024, our scientists will be presenting several posts using iSPCs, including novel, complex models of #neuroinflammation involving multiple cell types. https://okt.to/jJ5NQs #SfN24

At Charles River, our mission of creating healthier lives extends to improving access to life-saving treatments for children with cancer and other rare diseases. As a supporter of the Emily Whitehead Foundation and a sponsor of its Believe Ball, we are committed to helping families find support and ultimately a cure. Learn more about our commitment to the development of novel cell and gene therapies aimed at improving the lives of our youngest patients. https://okt.to/weN3dU #cellandgenetherapies #CDMO #childhoodcancer #raredisease #activatethecure

#Cancer research is usually about testing new treatment candidates. But giving an old drug a new purpose is also a way forward and sometimes achieves surprising success. Test your knowledge about these repurposed drugs for cancer with our Eureka Blog #quiz: https://okt.to/S1i8Gj

“Ultimately, however, investing in biomarkers to support drug development will pay out in the substantial increase in the probability of later success.” Stefan Kostense, PhD, discusses the discovery of preclinical biomarkers with GEN. https://okt.to/48dtHa

“Charles River is proud to work with the FOXG1 Research Foundation to advance its gene therapy through clinical trials. The FOXG1 patient population has an incredible unmet need, and we are looking forward to lending our expertise to FRF as they continue to trailblaze a path toward providing rare disease treatments.” Kerstin Dolph, CSVP, Global Manufacturing. Learn more about FRF and its replicable model for rare disease patient advocacy groups: https://okt.to/U01KV9

How can you improve accuracy and sustainability in your endotoxin testing processes? Endosafe cartridges reduce manual efforts and provide consistent, reliable results. Our guide “Selecting the Optimal Endosafe® Cartridge Sensitivity for Your Needs” provides factors to consider when selecting an Endosafe cartridge, to ensure you’re choosing the correct cartridge for your workflow. Discover key factors for selecting the right Endosafe cartridge in our guide: https://okt.to/iy4Jtl #EndotoxinTesting #Sustainability #Biotechnology #QualityControl #rCR #LAL #LaboratoryEfficiency #CharlesRiverLabs #Trillium #Endosafe

Endocrine disruption is one of the important safety hazards. Explore how endocrine disruption safety screening can help you manage your portfolio and development pipeline by profiling compounds at an early stage to predict any risks. https://okt.to/xmhdWK